APO Research
Talk to an analyst

APO RESEARCH · REPORT

Cefadroxil

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Cefadroxil Industry Growth and Trends Forecast to 2032

22 December 2025109 pages

Choose your research edition.

Industry ResearchCefadroxil Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Cefadroxil Industry Growth and Trends Forecast to 2032109 pages · $3,450 USDMarket StructureGlobal Cefadroxil Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Cefadroxil Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Cefadroxil Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Cefadroxil market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Cefadroxil is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Cefadroxil is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Cefadroxil is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Cefadroxil include Huafangpharm, Dongying Pharmaceutical, Qilu Antibiotics, Fukang, Union Chempharma, SALUBRIS, NCPC, Lupin Pharmaceuticals and LKPC, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Cefadroxil market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Cefadroxil market size, estimates, and forecasts are presented in terms of sales volume (tons) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Cefadroxil market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Cefadroxil.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Cefadroxil market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Cefadroxil Market by Company

Huafangpharm

Dongying Pharmaceutical

Qilu Antibiotics

Fukang

Union Chempharma

SALUBRIS

NCPC

Lupin Pharmaceuticals

LKPC

LIVZON

HPGC

CSPC

Covalent Laboratories

Alkem

Cefadroxil Segment by Type

USP

EP

Cefadroxil Segment by Application

Tablet

Capsule

Cefadroxil Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cefadroxil market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Cefadroxil and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cefadroxil.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Cefadroxil manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Cefadroxil in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of USP Table 2. Major Company of EP Table 3. Global Cefadroxil Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Cefadroxil Sales by Type (2021-2026) & (tons) Table 5. Global Cefadroxil Sales Market Share in Volume by Type (2021-2026) Table 6. Global Cefadroxil Sales by Type (2021-2026) & (US$ Million) Table 7. Global Cefadroxil Sales Market Share in Value by Type (2021-2026) Table 8. Global Cefadroxil Price by Type (2021-2026) & (US$/kg) Table 9. Global Cefadroxil Sales by Type (2027-2032) & (tons) Table 10. Global Cefadroxil Sales Market Share in Volume by Type (2027-2032) Table 11. Global Cefadroxil Sales by Type (2027-2032) & (US$ Million) Table 12. Global Cefadroxil Sales Market Share in Value by Type (2027-2032) Table 13. Global Cefadroxil Price by Type (2027-2032) & (US$/kg) Table 14. North America Cefadroxil Sales by Type (2021-2026) & (tons) Table 15. North America Cefadroxil Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Cefadroxil Sales by Type (2021-2026) & (tons) Table 17. Europe Cefadroxil Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Cefadroxil Sales by Type (2021-2026) & (tons) Table 19. Asia-Pacific Cefadroxil Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Cefadroxil Sales by Type (2021-2026) & (tons) Table 21. Latin America Cefadroxil Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Cefadroxil Sales by Type (2021-2026) & (tons) Table 23. Middle East and Africa Cefadroxil Sales by Type (2021-2026) & (US$ Million) Table 24. Cefadroxil Industry Trends Table 25. Cefadroxil Industry Drivers Table 26. Cefadroxil Industry Opportunities and Challenges Table 27. Cefadroxil Industry Restraints Table 28. Global Cefadroxil Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Cefadroxil Revenue Market Share by Company (2021-2026) Table 30. Global Cefadroxil Sales by Company (2021-2026) & (tons) Table 31. Global Cefadroxil Sales Share by Company (2021-2026) Table 32. Global Cefadroxil Market Price by Company (2021-2026) & (US$/kg) Table 33. Global Cefadroxil Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Cefadroxil Major Company Production Sites and Headquarters Table 35. Global Cefadroxil Company, Product Type & Application Table 36. Global Cefadroxil Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Cefadroxil by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Cefadroxil Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Cefadroxil Sales by Region (2021-2026) & (tons) Table 41. Global Cefadroxil Sales Market Share in Volume by Region (2021-2026) Table 42. Global Cefadroxil Sales by Region (2021-2026) & (US$ Million) Table 43. Global Cefadroxil Sales Market Share in Value by Region (2021-2026) Table 44. Global Cefadroxil Sales (tons), Value (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 45. Global Cefadroxil Sales by Region (2027-2032) & (tons) Table 46. Global Cefadroxil Sales Market Share in Volume by Region (2027-2032) Table 47. Global Cefadroxil Sales by Region (2027-2032) & (US$ Million) Table 48. Global Cefadroxil Sales Market Share in Value by Region (2027-2032) Table 49. Global Cefadroxil Sales (tons), Value (US$ Million), Price (US$/kg) and Gross Margin (2027-2032) Table 50. Global Cefadroxil Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Cefadroxil Sales by Application (2021-2026) & (tons) Table 52. Global Cefadroxil Sales Market Share in Volume by Application (2021-2026) Table 53. Global Cefadroxil Sales by Application (2021-2026) & (US$ Million) Table 54. Global Cefadroxil Sales Market Share in Value by Application (2021-2026) Table 55. Global Cefadroxil Price by Application (2021-2026) & (US$/kg) Table 56. Global Cefadroxil Sales by Application (2027-2032) & (tons) Table 57. Global Cefadroxil Sales Market Share in Volume by Application (2027-2032) Table 58. Global Cefadroxil Sales by Application (2027-2032) & (US$ Million) Table 59. Global Cefadroxil Sales Market Share in Value by Application (2027-2032) Table 60. Global Cefadroxil Price by Application (2027-2032) & (US$/kg) Table 61. North America Cefadroxil Sales by Application (2021-2026) & (tons) Table 62. North America Cefadroxil Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Cefadroxil Sales by Application (2021-2026) & (tons) Table 64. Europe Cefadroxil Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Cefadroxil Sales by Application (2021-2026) & (tons) Table 66. Asia-Pacific Cefadroxil Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Cefadroxil Sales by Application (2021-2026) & (tons) Table 68. Latin America Cefadroxil Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Cefadroxil Sales by Application (2021-2026) & (tons) Table 70. Middle East and Africa Cefadroxil Sales by Application (2021-2026) & (US$ Million) Table 71. Huafangpharm Company Information Table 72. Huafangpharm Business Overview Table 73. Huafangpharm Cefadroxil Sales (tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 74. Huafangpharm Cefadroxil Product Portfolio Table 75. Huafangpharm Recent Development Table 76. Dongying Pharmaceutical Company Information Table 77. Dongying Pharmaceutical Business Overview Table 78. Dongying Pharmaceutical Cefadroxil Sales (tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 79. Dongying Pharmaceutical Cefadroxil Product Portfolio Table 80. Dongying Pharmaceutical Recent Development Table 81. Qilu Antibiotics Company Information Table 82. Qilu Antibiotics Business Overview Table 83. Qilu Antibiotics Cefadroxil Sales (tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 84. Qilu Antibiotics Cefadroxil Product Portfolio Table 85. Qilu Antibiotics Recent Development Table 86. Fukang Company Information Table 87. Fukang Business Overview Table 88. Fukang Cefadroxil Sales (tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 89. Fukang Cefadroxil Product Portfolio Table 90. Fukang Recent Development Table 91. Union Chempharma Company Information Table 92. Union Chempharma Business Overview Table 93. Union Chempharma Cefadroxil Sales (tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 94. Union Chempharma Cefadroxil Product Portfolio Table 95. Union Chempharma Recent Development Table 96. SALUBRIS Company Information Table 97. SALUBRIS Business Overview Table 98. SALUBRIS Cefadroxil Sales (tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 99. SALUBRIS Cefadroxil Product Portfolio Table 100. SALUBRIS Recent Development Table 101. NCPC Company Information Table 102. NCPC Business Overview Table 103. NCPC Cefadroxil Sales (tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 104. NCPC Cefadroxil Product Portfolio Table 105. NCPC Recent Development Table 106. Lupin Pharmaceuticals Company Information Table 107. Lupin Pharmaceuticals Business Overview Table 108. Lupin Pharmaceuticals Cefadroxil Sales (tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 109. Lupin Pharmaceuticals Cefadroxil Product Portfolio Table 110. Lupin Pharmaceuticals Recent Development Table 111. LKPC Company Information Table 112. LKPC Business Overview Table 113. LKPC Cefadroxil Sales (tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 114. LKPC Cefadroxil Product Portfolio Table 115. LKPC Recent Development Table 116. LIVZON Company Information Table 117. LIVZON Business Overview Table 118. LIVZON Cefadroxil Sales (tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 119. LIVZON Cefadroxil Product Portfolio Table 120. LIVZON Recent Development Table 121. HPGC Company Information Table 122. HPGC Business Overview Table 123. HPGC Cefadroxil Sales (tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 124. HPGC Cefadroxil Product Portfolio Table 125. HPGC Recent Development Table 126. CSPC Company Information Table 127. CSPC Business Overview Table 128. CSPC Cefadroxil Sales (tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 129. CSPC Cefadroxil Product Portfolio Table 130. CSPC Recent Development Table 131. Covalent Laboratories Company Information Table 132. Covalent Laboratories Business Overview Table 133. Covalent Laboratories Cefadroxil Sales (tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 134. Covalent Laboratories Cefadroxil Product Portfolio Table 135. Covalent Laboratories Recent Development Table 136. Alkem Company Information Table 137. Alkem Business Overview Table 138. Alkem Cefadroxil Sales (tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 139. Alkem Cefadroxil Product Portfolio Table 140. Alkem Recent Development Table 141. North America Cefadroxil Market Size Growth Rate (CAGR) by Country (tons): 2021 VS 2025 VS 2032 Table 142. North America Cefadroxil Sales by Country (2021-2026) & (tons) Table 143. North America Cefadroxil Sales Market Share by Country (2021-2026) Table 144. North America Cefadroxil Sales Forecast by Country (2027-2032) & (tons) Table 145. North America Cefadroxil Sales Market Share Forecast by Country (2027-2032) Table 146. North America Cefadroxil Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 147. North America Cefadroxil Market Size by Country (2021-2026) & (US$ Million) Table 148. North America Cefadroxil Market Share by Country (2021-2026) Table 149. North America Cefadroxil Market Size Forecast by Country (2027-2032) & (US$ Million) Table 150. North America Cefadroxil Market Share Forecast by Country (2027-2032) Table 151. Europe Cefadroxil Market Size Growth Rate (CAGR) by Country (tons): 2021 VS 2025 VS 2032 Table 152. Europe Cefadroxil Sales by Country (2021-2026) & (tons) Table 153. Europe Cefadroxil Sales Market Share by Country (2021-2026) Table 154. Europe Cefadroxil Sales Forecast by Country (2027-2032) & (tons) Table 155. Europe Cefadroxil Sales Market Share Forecast by Country (2027-2032) Table 156. Europe Cefadroxil Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 157. Europe Cefadroxil Market Size by Country (2021-2026) & (US$ Million) Table 158. Europe Cefadroxil Market Share by Country (2021-2026) Table 159. Europe Cefadroxil Market Size Forecast by Country (2027-2032) & (US$ Million) Table 160. Europe Cefadroxil Market Share Forecast by Country (2027-2032) Table 161. Asia-Pacific Cefadroxil Market Size Growth Rate (CAGR) by Country (tons): 2021 VS 2025 VS 2032 Table 162. Asia-Pacific Cefadroxil Sales by Country (2021-2026) & (tons) Table 163. Asia-Pacific Cefadroxil Sales Market Share by Country (2021-2026) Table 164. Asia-Pacific Cefadroxil Sales Forecast by Country (2027-2032) & (tons) Table 165. Asia-Pacific Cefadroxil Sales Market Share Forecast by Country (2027-2032) Table 166. Asia-Pacific Cefadroxil Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 167. Asia-Pacific Cefadroxil Market Size by Country (2021-2026) & (US$ Million) Table 168. Asia-Pacific Cefadroxil Market Share by Country (2021-2026) Table 169. Asia-Pacific Cefadroxil Market Size Forecast by Country (2027-2032) & (US$ Million) Table 170. Asia-Pacific Cefadroxil Market Share Forecast by Country (2027-2032) Table 171. Latin America Cefadroxil Market Size Growth Rate (CAGR) by Country (tons): 2021 VS 2025 VS 2032 Table 172. Latin America Cefadroxil Sales by Country (2021-2026) & (tons) Table 173. Latin America Cefadroxil Sales Market Share by Country (2021-2026) Table 174. Latin America Cefadroxil Sales Forecast by Country (2027-2032) & (tons) Table 175. Latin America Cefadroxil Sales Market Share Forecast by Country (2027-2032) Table 176. Latin America Cefadroxil Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 177. Latin America Cefadroxil Market Size by Country (2021-2026) & (US$ Million) Table 178. Latin America Cefadroxil Market Share by Country (2021-2026) Table 179. Latin America Cefadroxil Market Size Forecast by Country (2027-2032) & (US$ Million) Table 180. Latin America Cefadroxil Market Share Forecast by Country (2027-2032) Table 181. Middle East and Africa Cefadroxil Market Size Growth Rate (CAGR) by Country (tons): 2021 VS 2025 VS 2032 Table 182. Middle East and Africa Cefadroxil Sales by Country (2021-2026) & (tons) Table 183. Middle East and Africa Cefadroxil Sales Market Share by Country (2021-2026) Table 184. Middle East and Africa Cefadroxil Sales Forecast by Country (2027-2032) & (tons) Table 185. Middle East and Africa Cefadroxil Sales Market Share Forecast by Country (2027-2032) Table 186. Middle East and Africa Cefadroxil Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 187. Middle East and Africa Cefadroxil Market Size by Country (2021-2026) & (US$ Million) Table 188. Middle East and Africa Cefadroxil Market Share by Country (2021-2026) Table 189. Middle East and Africa Cefadroxil Market Size Forecast by Country (2027-2032) & (US$ Million) Table 190. Middle East and Africa Cefadroxil Market Share Forecast by Country (2027-2032) Table 191. Key Raw Materials Table 192. Raw Materials Key Suppliers Table 193. Cefadroxil Distributors List Table 194. Cefadroxil Customers List Table 195. Research Programs/Design for This Report Table 196. Authors List of This Report Table 197. Secondary Sources Table 198. Primary Sources List of Figures Figure 1. Cefadroxil Image Figure 2. Global Cefadroxil Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Cefadroxil Market Size (2021-2032) & (US$ Million) Figure 4. Global Cefadroxil Sales (2021-2032) & (tons) Figure 5. USP Image Figure 6. Global USP Sales YoY Growth (2021-2032) & (tons) Figure 7. EP Image Figure 8. Global EP Sales YoY Growth (2021-2032) & (tons) Figure 9. Global Cefadroxil Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Cefadroxil Market Share by Type 2025 VS 2032 Figure 11. North America Cefadroxil Sales Market Share in Volume by Type in 2025 Figure 12. North America Cefadroxil Sales Market Share in Value by Type in 2025 Figure 13. Europe Cefadroxil Sales Market Share in Volume by Type in 2025 Figure 14. Europe Cefadroxil Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Cefadroxil Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Cefadroxil Sales Market Share in Value by Type in 2025 Figure 17. Latin America Cefadroxil Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Cefadroxil Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Cefadroxil Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Cefadroxil Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Cefadroxil Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Tablet Image Figure 24. Global Tablet Sales YoY Growth (2021-2032) & (tons) Figure 25. Capsule Image Figure 26. Global Capsule Sales YoY Growth (2021-2032) & (tons) Figure 27. Global Cefadroxil Market Size Overview by Application (2021-2032) & (US$ Million) Figure 28. Global Cefadroxil Market Share by Application 2025 VS 2032 Figure 29. North America Cefadroxil Sales Market Share in Volume by Application in 2025 Figure 30. North America Cefadroxil Sales Market Share in Value by Application in 2025 Figure 31. Europe Cefadroxil Sales Market Share in Volume by Application in 2025 Figure 32. Europe Cefadroxil Sales Market Share in Value by Application in 2025 Figure 33. Asia-Pacific Cefadroxil Sales Market Share in Volume by Application in 2025 Figure 34. Asia-Pacific Cefadroxil Sales Market Share in Value by Application in 2025 Figure 35. Latin America Cefadroxil Sales Market Share in Volume by Application in 2025 Figure 36. Latin America Cefadroxil Sales Market Share in Value by Application in 2025 Figure 37. Middle East and Africa Cefadroxil Sales Market Share in Volume by Application in 2025 Figure 38. Middle East and Africa Cefadroxil Sales Market Share in Value by Application in 2025 Figure 39. North America Cefadroxil Sales by Country: 2021 VS 2025 VS 2032 (tons) Figure 40. North America Cefadroxil Sales Share by Country: 2021 VS 2025 VS 2032 Figure 41. North America Cefadroxil Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 42. North America Cefadroxil Market Share by Country: 2021 VS 2025 VS 2032 Figure 43. Europe Cefadroxil Sales by Country: 2021 VS 2025 VS 2032 (tons) Figure 44. Europe Cefadroxil Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Cefadroxil Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. Europe Cefadroxil Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Asia-Pacific Cefadroxil Sales by Country: 2021 VS 2025 VS 2032 (tons) Figure 48. Asia-Pacific Cefadroxil Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Cefadroxil Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Asia-Pacific Cefadroxil Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Latin America Cefadroxil Sales by Country: 2021 VS 2025 VS 2032 (tons) Figure 52. Latin America Cefadroxil Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Cefadroxil Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Latin America Cefadroxil Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Middle East and Africa Cefadroxil Sales by Country: 2021 VS 2025 VS 2032 (tons) Figure 56. Middle East and Africa Cefadroxil Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Cefadroxil Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Middle East and Africa Cefadroxil Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Cefadroxil Value Chain Figure 60. Key Raw Materials Price Figure 61. Manufacturing Cost Structure Figure 62. Cefadroxil Production Mode & Process Figure 63. Direct Comparison with Distribution Share Figure 64. Distributors Profiles Figure 65. Years Considered Figure 66. Research Process Figure 67. Key Executives Interviewed

Scope & coverage.

Types
  • USP
  • EP
Applications
  • Tablet
  • Capsule
Companies covered
  • Huafangpharm
  • Dongying Pharmaceutical
  • Qilu Antibiotics
  • Fukang
  • Union Chempharma
  • SALUBRIS
  • NCPC
  • Lupin Pharmaceuticals
  • LKPC
  • LIVZON
  • HPGC
  • CSPC
  • Covalent Laboratories
  • Alkem

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Cefadroxil Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Cefadroxil Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Cefadroxil Market by Type
  6. 1.3.1 USP
  7. 1.3.2 EP
  8. 1.4 Global Cefadroxil Market Size by Type
  9. 1.4.1 Global Cefadroxil Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Cefadroxil Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Cefadroxil Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Cefadroxil Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Cefadroxil Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Cefadroxil Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Cefadroxil Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Cefadroxil Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Cefadroxil Industry Trends
  2. 2.2 Cefadroxil Industry Drivers
  3. 2.3 Cefadroxil Industry Opportunities and Challenges
  4. 2.4 Cefadroxil Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Cefadroxil Revenue (2021-2026)
  2. 3.2 Global Top Players by Cefadroxil Sales (2021-2026)
  3. 3.3 Global Top Players by Cefadroxil Price (2021-2026)
  4. 3.4 Global Cefadroxil Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Cefadroxil Major Company Production Sites & Headquarters
  6. 3.6 Global Cefadroxil Company, Product Type & Application
  7. 3.7 Global Cefadroxil Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Cefadroxil Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Cefadroxil Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Cefadroxil Tier 1, Tier 2, and Tier 3
4 Cefadroxil Regional Status and Outlook
  1. 4.1 Global Cefadroxil Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Cefadroxil Historic Market Size by Region
  3. 4.2.1 Global Cefadroxil Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Cefadroxil Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Cefadroxil Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Cefadroxil Forecasted Market Size by Region
  7. 4.3.1 Global Cefadroxil Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Cefadroxil Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Cefadroxil Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Cefadroxil by Application
  1. 5.1 Cefadroxil Market by Application
  2. 5.1.1 Tablet
  3. 5.1.2 Capsule
  4. 5.2 Global Cefadroxil Market Size by Application
  5. 5.2.1 Global Cefadroxil Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Cefadroxil Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Cefadroxil Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Cefadroxil Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Cefadroxil Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Cefadroxil Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Cefadroxil Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Cefadroxil Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Huafangpharm
  2. 6.1.1 Huafangpharm Company Information
  3. 6.1.2 Huafangpharm Business Overview
  4. 6.1.3 Huafangpharm Cefadroxil Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Huafangpharm Cefadroxil Product Portfolio
  6. 6.1.5 Huafangpharm Recent Developments
  7. 6.2 Dongying Pharmaceutical
  8. 6.2.1 Dongying Pharmaceutical Company Information
  9. 6.2.2 Dongying Pharmaceutical Business Overview
  10. 6.2.3 Dongying Pharmaceutical Cefadroxil Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Dongying Pharmaceutical Cefadroxil Product Portfolio
  12. 6.2.5 Dongying Pharmaceutical Recent Developments
  13. 6.3 Qilu Antibiotics
  14. 6.3.1 Qilu Antibiotics Company Information
  15. 6.3.2 Qilu Antibiotics Business Overview
  16. 6.3.3 Qilu Antibiotics Cefadroxil Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Qilu Antibiotics Cefadroxil Product Portfolio
  18. 6.3.5 Qilu Antibiotics Recent Developments
  19. 6.4 Fukang
  20. 6.4.1 Fukang Company Information
  21. 6.4.2 Fukang Business Overview
  22. 6.4.3 Fukang Cefadroxil Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Fukang Cefadroxil Product Portfolio
  24. 6.4.5 Fukang Recent Developments
  25. 6.5 Union Chempharma
  26. 6.5.1 Union Chempharma Company Information
  27. 6.5.2 Union Chempharma Business Overview
  28. 6.5.3 Union Chempharma Cefadroxil Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Union Chempharma Cefadroxil Product Portfolio
  30. 6.5.5 Union Chempharma Recent Developments
  31. 6.6 SALUBRIS
  32. 6.6.1 SALUBRIS Company Information
  33. 6.6.2 SALUBRIS Business Overview
  34. 6.6.3 SALUBRIS Cefadroxil Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 SALUBRIS Cefadroxil Product Portfolio
  36. 6.6.5 SALUBRIS Recent Developments
  37. 6.7 NCPC
  38. 6.7.1 NCPC Company Information
  39. 6.7.2 NCPC Business Overview
  40. 6.7.3 NCPC Cefadroxil Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 NCPC Cefadroxil Product Portfolio
  42. 6.7.5 NCPC Recent Developments
  43. 6.8 Lupin Pharmaceuticals
  44. 6.8.1 Lupin Pharmaceuticals Company Information
  45. 6.8.2 Lupin Pharmaceuticals Business Overview
  46. 6.8.3 Lupin Pharmaceuticals Cefadroxil Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Lupin Pharmaceuticals Cefadroxil Product Portfolio
  48. 6.8.5 Lupin Pharmaceuticals Recent Developments
  49. 6.9 LKPC
  50. 6.9.1 LKPC Company Information
  51. 6.9.2 LKPC Business Overview
  52. 6.9.3 LKPC Cefadroxil Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 LKPC Cefadroxil Product Portfolio
  54. 6.9.5 LKPC Recent Developments
  55. 6.10 LIVZON
  56. 6.10.1 LIVZON Company Information
  57. 6.10.2 LIVZON Business Overview
  58. 6.10.3 LIVZON Cefadroxil Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 LIVZON Cefadroxil Product Portfolio
  60. 6.10.5 LIVZON Recent Developments
  61. 6.11 HPGC
  62. 6.11.1 HPGC Company Information
  63. 6.11.2 HPGC Business Overview
  64. 6.11.3 HPGC Cefadroxil Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 HPGC Cefadroxil Product Portfolio
  66. 6.11.5 HPGC Recent Developments
  67. 6.12 CSPC
  68. 6.12.1 CSPC Company Information
  69. 6.12.2 CSPC Business Overview
  70. 6.12.3 CSPC Cefadroxil Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 CSPC Cefadroxil Product Portfolio
  72. 6.12.5 CSPC Recent Developments
  73. 6.13 Covalent Laboratories
  74. 6.13.1 Covalent Laboratories Company Information
  75. 6.13.2 Covalent Laboratories Business Overview
  76. 6.13.3 Covalent Laboratories Cefadroxil Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Covalent Laboratories Cefadroxil Product Portfolio
  78. 6.13.5 Covalent Laboratories Recent Developments
  79. 6.14 Alkem
  80. 6.14.1 Alkem Company Information
  81. 6.14.2 Alkem Business Overview
  82. 6.14.3 Alkem Cefadroxil Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 Alkem Cefadroxil Product Portfolio
  84. 6.14.5 Alkem Recent Developments
7 North America by Country
  1. 7.1 North America Cefadroxil Sales by Country
  2. 7.1.1 North America Cefadroxil Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Cefadroxil Sales by Country (2021-2026)
  4. 7.1.3 North America Cefadroxil Sales Forecast by Country (2027-2032)
  5. 7.2 North America Cefadroxil Market Size by Country
  6. 7.2.1 North America Cefadroxil Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Cefadroxil Market Size by Country (2021-2026)
  8. 7.2.3 North America Cefadroxil Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Cefadroxil Sales by Country
  2. 8.1.1 Europe Cefadroxil Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Cefadroxil Sales by Country (2021-2026)
  4. 8.1.3 Europe Cefadroxil Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Cefadroxil Market Size by Country
  6. 8.2.1 Europe Cefadroxil Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Cefadroxil Market Size by Country (2021-2026)
  8. 8.2.3 Europe Cefadroxil Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Cefadroxil Sales by Country
  2. 9.1.1 Asia-Pacific Cefadroxil Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Cefadroxil Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Cefadroxil Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Cefadroxil Market Size by Country
  6. 9.2.1 Asia-Pacific Cefadroxil Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Cefadroxil Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Cefadroxil Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Cefadroxil Sales by Country
  2. 10.1.1 South America Cefadroxil Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Cefadroxil Sales by Country (2021-2026)
  4. 10.1.3 South America Cefadroxil Sales Forecast by Country (2027-2032)
  5. 10.2 South America Cefadroxil Market Size by Country
  6. 10.2.1 South America Cefadroxil Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Cefadroxil Market Size by Country (2021-2026)
  8. 10.2.3 South America Cefadroxil Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Cefadroxil Sales by Country
  2. 11.1.1 Middle East and Africa Cefadroxil Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Cefadroxil Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Cefadroxil Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Cefadroxil Market Size by Country
  6. 11.2.1 Middle East and Africa Cefadroxil Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Cefadroxil Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Cefadroxil Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Cefadroxil Value Chain Analysis
  2. 12.1.1 Cefadroxil Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Cefadroxil Production Mode & Process
  7. 12.2 Cefadroxil Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Cefadroxil Distributors
  10. 12.2.3 Cefadroxil Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst